Latest Breaking News On - ஆரோக்கியம் அறிவியல் இன்க் - Page 12 : comparemela.com
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate WBT, COHR, PRAH, TLND; Shareholders Are Encouraged to Contact the Firm
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate WBT, COHR, PRAH, TLND; Shareholders Are Encouraged to Contact the Firm
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
PRA Health Sciences Inc. (NASDAQ: PRAH)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
PRA Health Sciences Inc. (NASDAQ: PRAH) in connection with the proposed acquisition of the company by ICON plc ( ICLR ). Under the terms of the merger agreement, PRAH shareholders will receive $80.00 in cash and 0.4125 shares of stock for each share of PRAH common stock that they own, representing implied per-share merger consideration of approximately $165.12 based upon ICLR s April 20, 2021 closing price of $206.36. If you own TPCO shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/prah/
The Worldwide Virtual Clinical Trials Industry is Expected to Reach $10 Billion by 2026
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
The Global Virtual Clinical Trials Market size is expected to reach $10 billion by 2026, rising at a market growth of 6.5% CAGR during the forecast period. Virtual Clinical Trials (VCTs) are also known as remote or decentralized trails, are a comparatively new but still underused technique of carrying out clinical research taking complete benefit of technologies like apps, online social interaction platforms, and electronic monitoring tools. The market is significantly driven by growth in R&D activities, the growing digitization in healthcare, and the adoption of telehealth. Moreover, advances in technology, collaborations between clinical research companies, biotechnology companies, and pharmaceutical and support initiatives from governments are expected to boost the market.
vimarsana © 2020. All Rights Reserved.